Generic Pharmaceuticals Global Market Opportunities And Strategies To 2033
Description
Generic Pharmaceuticals Global Market Opportunities And Strategies To 2033
Including: 1) By Type: Biosimilars; Generics 2) By Therapy: Oncology Drugs; Central Nervous System Drugs; Anti-Infective Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs3) By Drug Delivery: Oral; Injectables; Dermal/Topical4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Sun Pharmaceutical Industries Ltd.; Viatris Inc.; Abbott Laboratories
Generic Pharmaceuticals Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for generic pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The generic pharmaceuticals market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider generic pharmaceuticals market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by drug delivery, by therapy and by distribution channel.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the generic pharmaceuticals market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by drug delivery, by therapy and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for generic pharmaceuticals providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
1) By Type: Biosimilars; Generics
2) By Therapy: Oncology Drugs; Central Nervous System Drugs; Anti-Infective Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Others
3) By Drug Delivery: Oral; Injectables; Dermal/Topical; Other Drug Delivery
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Sun Pharmaceutical Industries Ltd.; Viatris Inc.; Abbott Laboratories
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; generic pharmaceuticals indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
327 Pages
- 1 Executive Summary
- 1.1 Generic Pharmaceuticals – Market Attractiveness And Macro economic Landscape
- 2 Table Of Contents
- 3 List Of Tables
- 4 List Of Figures
- 5 Report Structure
- 6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Generic Pharmaceuticals Market Definition And Segmentations
- 6.4 Market Segmentation By Type
- 6.4.1 Biosimilar
- 6.4.2 Generics
- 6.5 Market Segmentation By Drug Delivery
- 6.5.1 Oral
- 6.5.2 Injectables
- 6.5.3 Dermal/Topical
- 6.5.4 Other Drug Delivery
- 6.6 Market Segmentation By Therapy
- 6.6.1 Oncology Drugs
- 6.6.2 Central Nervous System (CNS) Drugs
- 6.6.3 Anti-Infective Drugs
- 6.6.4 Respiratory Diseases Drugs
- 6.6.5 Cardiovascular Drugs
- 6.6.6 Metabolic Disorders Drugs
- 6.6.7 Musculoskeletal Disorders Drugs
- 6.6.8 Others
- 6.7 Market Segmentation By Distribution Channel
- 6.7.1 Hospital Pharmacies
- 6.7.2 Retail Pharmacies
- 6.7.3 Online Pharmacies
- 7 Major Market Trends
- 7.1 Launch Of New Generic Pharmaceuticals To Broaden Patient Access To Essential Therapeutics Across Diverse Health Conditions
- 7.2 Introduction Of Innovative Ready-To-Use Injectable Formulations To Enhance Patient Convenience In Chemotherapy Regimens
- 7.3 Strategic Partnerships And Collaborations Among Major Players To Enhance Product Offerings
- 7.4 Strategic Launch Of Generic Oral Solutions To Enhance Market Competitiveness And Patient Access To Essential Medications
- 8 Generic Pharmaceuticals Market – Macro-Economic Scenario
- 8.1 COVID-19 Impact On The Generic Pharmaceuticals Market
- 8.2 Impact Of The War In Ukraine On The Generic Pharmaceuticals Market
- 8.3 Impact Of High Inflation On The Generic Pharmaceuticals Market
- 9 Global Market Size and Growth
- 9.1 Market Size
- 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 – 2023
- 9.2.2 Market Restraints 2018 – 2023
- 9.3 Forecast Market Growth, 2023 – 2028, 2033 F Value ($ Million)
- 9.3.1 Market Drivers 2023 – 2028
- 9.3.2 Market Restraints 2023 – 2028
- 10 Global Generic Pharmaceuticals Market Segmentation
- 10.1 Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 10.2 Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 10.3 Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 10.4 Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 11 Generic Pharmaceuticals Market, Regional and Country Analysis
- 11.1 Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 11.2 Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12 Asia-Pacific Market
- 12.1 Summary
- 12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
- 12.3 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.4 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.5 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.6 China Market
- 12.7 Summary
- 12.8 Market Overview
- 12.8.1 Country Information
- 12.8.2 Market Information
- 12.8.3 Background Information
- 12.8.4 Government Initiatives
- 12.8.5 Regulations
- 12.8.6 Regulatory Bodies
- 12.8.7 Major Associations
- 12.8.8 Taxes Levied
- 12.8.9 Corporate Tax Structure
- 12.8.10 Investments
- 12.8.11 Major Companies
- 12.9 China Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.10 China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.11 China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.12 India Market
- 12.13 India Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.14 India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.15 India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.16 Japan Market
- 12.17 Japan Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.18 Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.19 Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.20 Australia Market
- 12.21 Australia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.22 Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.23 Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.24 Indonesia Market
- 12.25 Indonesia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.26 Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.27 Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.28 South Korea Market
- 12.29 South Korea Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.30 South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.31 South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13 Western Europe Market
- 13.1 Summary
- 13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Investments
- 13.2.11 Major Companies
- 13.3 Western Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.4 Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.5 Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.6 Western Europe Generic Pharmaceuticals Market: Country Analysis
- 13.7 UK Market
- 13.8 UK Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.9 UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.10 UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.11 Germany Market
- 13.12 Germany Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.13 Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.14 Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.15 France Market
- 13.16 France Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.17 France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.18 France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.19 Italy Market
- 13.20 Italy Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.21 Italy Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.22 Italy Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.23 Spain Market
- 13.24 Spain Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.25 Spain Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.26 Spain Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14 Eastern Europe Market
- 14.1 Summary
- 14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
- 14.3 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.4 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.5 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.6 Eastern Europe Generic Pharmaceuticals Market: Country Analysis
- 14.7 Russia Market
- 14.8 Russia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.9 Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.10 Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15 North America Market
- 15.1 Summary
- 15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
- 15.3 North America Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.4 North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.5 North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.6 North America Generic Pharmaceuticals Market: Country Analysis
- 15.7 USA Market
- 15.8 Summary
- 15.9 Market Overview
- 15.9.1 Country Information
- 15.9.2 Market Information
- 15.9.3 Background Information
- 15.9.4 Government Initiatives
- 15.9.5 Regulations
- 15.9.6 Regulatory Bodies
- 15.9.7 Major Associations
- 15.9.8 Taxes Levied
- 15.9.9 Corporate Tax Structure
- 15.9.10 Investments
- 15.9.11 Major Companies
- 15.10 USA Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.11 USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.12 USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.13 Canada Market
- 15.14 Canada Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.15 Canada Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.16 Canada Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16 South America Market
- 16.1 Summary
- 16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
- 16.3 South America Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.4 South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.5 South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.6 South America Generic Pharmaceuticals Market: Country Analysis
- 16.7 Brazil Market
- 16.8 Brazil Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.9 Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.10 Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 17 Middle East Market
- 17.1 Summary
- 17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
- 17.3 Middle East Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 17.4 Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 17.5 Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 18 Africa Market
- 18.1 Summary
- 18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Investments
- 18.2.11 Major Companies
- 18.3 Africa Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 18.4 Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 18.5 Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 19 Competitive Landscape and Company Profiles
- 19.1 Company Profiles
- 19.2 Teva Pharmaceutical Industries Ltd
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
- 19.3 Sandoz Group AG
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
- 19.4 Sun Pharmaceutical Industries Ltd
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
- 19.5 Viatris Inc
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
- 19.6 Abbott Laboratories
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Financial Overview
- 20 Other Major And Innovative Companies
- 20.1 Dr. Reddy's Laboratories
- 20.1.1 Company Overview
- 20.1.2 Products And Services
- 20.2 Cipla Limited
- 20.2.1 Company Overview
- 20.2.2 Products And Services
- 20.3 Fresenius Kabi AG
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.4 Zydus Lifesciences Limited
- 20.4.1 Company Overview
- 20.4.2 Products And Services
- 20.5 Stada Arzneimittel AG
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.6 Lupin Inc
- 20.6.1 Company Overview
- 20.6.2 Products And Services
- 20.7 Alkem Laboratories Ltd
- 20.7.1 Company Overview
- 20.7.2 Products And Services
- 20.8 Amneal Pharmaceuticals, Inc
- 20.8.1 Company Overview
- 20.8.2 Products And Services
- 20.9 Torrent Pharmaceuticals Ltd
- 20.9.1 Company Overview
- 20.9.2 Products And Services
- 20.1 Sawai Group Holdings Co., Ltd
- 20.10.1 Company Overview
- 20.10.2 Products And Services
- 20.11 Sanofi S.A.
- 20.11.1 Company Overview
- 20.11.2 Products And Services
- 20.12 Hikma Pharmaceuticals PLC
- 20.12.1 Company Overview
- 20.12.2 Products And Services
- 20.13 Aurobindo Pharma Limited
- 20.13.1 Company Overview
- 20.13.2 Products And Services
- 20.14 Aspen Pharmacare Holdings Ltd
- 20.14.1 Company Overview
- 20.14.2 Products And Services
- 20.15 Endo International plc
- 20.15.1 Company Overview
- 20.15.2 Products And Services
- 21 Competitive Benchmarking
- 22 Competitive Dashboard
- 23 Key Mergers And Acquisitions
- 23.1 Farmak Pharmaceuticals UK Ltd. Acquired A&S Pharma Holdings
- 23.2 Platinum Equity Acquired A Majority Stake In Inventia Healthcare Limited
- 23.3 Lotus Pharmaceuticals Acquired Teva Pharma Thailand
- 23.4 Apotex Acquired Searchlight Pharma
- 23.5 Genpharmasec Limited Acquired A Majority Stake In DHPL
- 23.6 Lupin Limited Acquired Medisol
- 23.7 Sun Pharmaceutical Industries Ltd. Acquired Taro Pharmaceutical Industries Ltd.
- 23.8 Dr. Reddy's Laboratories Acquired Mayne Pharma’s US Generic Prescription Product Portfolio
- 23.9 Dr. Reddy's Laboratories Acquired Eton’s Branded And Generic Injectable Products Portfolio
- 24 Opportunities And Strategies
- 24.1 Global Generic Pharmaceuticals Market In 2028 – Countries Offering Most New Opportunities
- 24.2 Global Generic Pharmaceuticals Market In 2028 – Segments Offering Most New Opportunities
- 24.3 Global Generic Pharmaceuticals Market In 2028 – Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies
- 25 Generic Pharmaceuticals Market Conclusions And Recommendations
- 25.1 Conclusions
- 25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People
- 26 Appendix
- 26.1 Geographies Covered
- 26.2 Market Data Sources
- 26.3 Research Methodology
- 26.4 Currencies
- 26.5 The Business Research Company
- 26.6 Copyright and Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
